Chemestmed is attending BIO Europe in Stockholm
Chemestmed is attending BIOEurope! Join us in Stockholm, Sweden, from November 4–6, 2024, to celebrate the event's 30th anniversary. Meet our team Dr. Sigrid Selberg, Prof. Mati Karelson and Prof. Jaanus Harro.
We will showcase our cutting-edge drug discovery platform, targeting RNA N6-methyladenosine (m6A) regulation in cells through key enzymes like METTL3/METTL14/WTAP and demethylases (AlkBH5 and FTO).
Our focus will be on the progress of in vivo proof-of-concept studies with small-molecule METTL3/METTL14/WTAP activators - methylation repairers, tackling anxiety disorders, Parkinson’s, T2DM, and obesity.
ā
Looking for strategic partnerships—let’s connect and explore how we can collaborate. Schedule a meeting with our team at BIO Europe and join us on the path to innovative drug design!